http://orcid.org/0000-0001-5757-8346
Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Filippo Lagi, Annarita Botta, Arturo Ciccullo, Chiara Picarelli, Massimiliano Fabbiani, Simona di Giambenedetto, Vanni Borghi, Cristina Mussini, Alessandro Bartoloni & Gaetana Sterrantino. (2021) Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study. HIV Research & Clinical Practice 22:4, pages 96-101.
Read now
Read now
Articles from other publishers (8)
Ana González-Cordón, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masiá, Mark Gompels, Stephane De Wit, Eric Florence, Stefan Esser, François Raffi, Georg Behrens, Anton Pozniak, Jose M Gatell, Esteban Martínez, Linos Vandekerckhove, Els Caluwé, Stephane De Wit, Coca Necsoi, Eric Florence, Maartje Van Frankenhuijsen, François Raffi, Clotilde Allavena, Véronique Reliquet, David Boutoille, Morane Cavellec, Elisabeth André-Garnier, Audrey Rodallec, Thierry Le Tourneau, Jérôme Connault, Jean-Michel Molina, Samuel Ferret, Miresta Previlon, Yazdan Yazdanpanah, Roland Landman, Véronique Joly, Adriana Pinto, Christine Katlama, Fabienne Caby, Nadine Ktorza, Luminita Schneider, Christoph Stephan, Timo Wolf, Gundolf Schüttfort, Juergen Rockstroh, Jan-Christian Wasmuth, Carolynne Schwarze-Zander, Christoph Boesecke, Hans-Jurgen Stellbrink, Christian Hoffmann, Michael Sabranski, Stephan Esser, Robert Jablonka, Heidi Wiehler, Georg Behrens, Matthias Stoll, Gerrit Ahrenstorf, Giovanni Guaraldi, Giulia Nardini, Barbara Beghetto, Antonella D’Arminio Montforte, Teresa Bini, Viola Cogliandro, Massimo Di Pietro, Francesco Maria Fusco, Massimo Galli, Stefano Rusconi, Andrea Giacomelli, Paola Meraviglia, Esteban Martinez, Ana González-Cordón, José Maria Gatell, Berta Torres, Pere Domingo, Gracia Mateo, Mar Gutierrez, Joaquin Portilla, Esperanza Merino, Sergio Reus, Vicente Boix, Mar Masia, Félix Gutiérrez, Sergio Padilla, Bonaventura Clotet, Eugenia Negredo, Anna Bonjoch, José L Casado, Sara Bañón-Escandell, Jose Saban, Africa Duque, Daniel Podzamczer, Maria Saumoy, Laura Acerete, Juan Gonzalez-Garcia, José Ignacio Bernardino, José Ramón Arribas, Victor Hontañón, Graeme Moyle, Nicole Pagani, Margherita Bracchi, Jaime Vera, Amanda Clarke, Tanya Adams, Celia Richardson, Alan Winston, Borja Mora-Peris, Scott Mullaney, Laura Waters, Nahum de Esteban, Ana Milinkovic, Sarah Pett, Julie Fox, Juan Manuel Tiraboschi, Margaret Johnson, Mike Youle, Chloe Orkin, Simon Rackstraw, James Hand, Mark Gompels, Louise Jennings, Jane Nicholls & Sarah Johnston. (2023) Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Sahera Dirajlal-Fargo, Monika Strah, Kate Ailstock, Abdus Sattar, Christine Karungi, Rashidah Nazzinda, Cissy Kityo, Victor Musiime, Nicholas Funderburg & Grace A. McComsey. (2023) Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV. Frontiers in Immunology 14.
Crossref
Crossref
Stephanie Shiau, Denise L Jacobson, Yanling Huo, Deborah Kacanek, Lynn M Yee, David B Williams, Lisa B Haddad, Lena Serghides, Kathleen Powis, Rhoda S Sperling, Paige L Williams, Jennifer Jao, Ellen Chadwick, Margaret Ann Sanders, Kathleen Malee, Mary Paul, Ruth Eser-Jose, Chivon McMullen-Jackson, Lynnette Harris, Murli Purswani, Mahoobullah Mirza Baig, Alma Villegas, Marvin Alvarado, Lisa-Gaye Robinson, Jawara Dia Cooley, James Blood, Patricia Garvie, William Borkowsky, Nagamah Sandra Deygoo, Jennifer Lewis, Arry Dieudonne, Linda Bettica, Juliette Johnson, Karen Surowiec, Katherine Knapp, Jamie Russell-Bell, Megan Wilkins, Stephanie Love, Nicolas Rosario, Lourdes Angeli-Nieves, Vivian Olivera, Stephan Kohlhoff, Ava Dennie, Jean Kaye, Jenny Wallier, Karen Craig, Margarita Silio, Patricia Sirois, Cecelia Hutto, Paige Hickman, Julie Huldtquist, Dan Marullo, Stephen A Spector, Veronica Figueroa, Megan Loughran, Sharon Nichols, Elizabeth McFarland, Christine Kwon, Carrie Glenny, Jennifer Englund, Mobeen Rathore, Saniyyah Mahmoudi, Sarah El-Hassan, Jamilah Tejan, Karen Hayani, Lourdes Richardson, Renee Smith, Alina Miller, Gwendolyn Scott, Gustavo Gil Garcia, Gabriel Fernandez, Anai Cuadra, Toni Frederick, Mariam Davtyan, Guadalupe Morales-Avendano, Zoe M Rodriguez, Lizmarie Torres & Nydia Scalley. (2023) Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States. The Journal of Infectious Diseases 227:5, pages 720-730.
Crossref
Crossref
Josep M Llibre, Pedro E Cahn, Janet Lo, Tristan J Barber, Cristina Mussini, Berend J van Welzen, Beatriz Hernandez, Cynthia Donovan, Michelle Kisare, Myooran Sithamparanathan & Jean van Wyk. (2022) Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review. Open Forum Infectious Diseases 9:4.
Crossref
Crossref
Massimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, Letizia Oreni, Filippo Lagi, Luigi Celani, Manuela Colafigli, Andrea De Vito, Maria Mazzitelli, Alex Dusina, Miriam Durante, Francesca Montagnani, Stefano Rusconi, Amedeo Capetti, Gaetana Sterrantino, Gabriella D’Ettorre, Simona Di Giambenedetto, Giacomo Zanelli, Gianmaria Baldin, Alberto Borghetti, Alessandra Latini, Claudio Mastroianni, Vanni Borghi, Cristina Mussini, Maria Vittoria Cossu, Andrea Giacomelli, Tiziana Formenti, Enrico Maria Trecarichi, Carlo Torti, Giordano Madeddu, Jacopo Vecchiet, Francesca Vignale & Andrea Giacometti. (2021)
Efficacy and durability of two‐
vs
. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort
. HIV Medicine 22:9, pages 843-853.
Crossref
Crossref
Valeria Cento & Carlo Federico Perno. (2021) Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era. Diagnostics 11:5, pages 809.
Crossref
Crossref
Massimiliano Fabbiani, Alberto Borghetti, Nicola Squillace, Manuela Colafigli, Lucia Taramasso, Andrea Lombardi, Barbara Rossetti, Arturo Ciccullo, Elisa Colella, Chiara Picarelli, Marco Berruti, Alessandra Latini, Francesca Montagnani, Margherita Sambo, Antonio Di Biagio, Andrea Gori, Simona Di Giambenedetto & Alessandra Bandera. (2021) Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 86:1, pages 119-127.
Crossref
Crossref
Leonardo Calza, Vincenzo Colangeli, Marco Borderi, Diletta Testi, Bianca Granozzi, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2020) Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy. Journal of Antimicrobial Chemotherapy 75:11, pages 3327-3333.
Crossref
Crossref